If your doctor recommends treatment for opioid use disorder (OUD), they might prescribe Sublocade (buprenorphine). Sublocade is a prescription drug that’s used to treat OUD. This article describes the ...
If you’re considering treatment for opioid use disorder (OUD), your doctor may recommend Sublocade. It’s prescribed as part of a complete treatment program to manage opioid addiction in adults with ...
Rapid Initiation Protocol Reduces Time to Treatment with SUBLOCADE® From One Week to One Hour, A Significant Advancement in the Treatment of Moderate to Severe Opioid Use Disorder (OUD) These FDA ...
With the significant treatment gap, Indivior is well positioned for growth as more patients receive treatment for Opioid Use Disorder. Sublocade, the first FDA-approved buprenorphine LAI for OUD, has ...
(Sharecast News) - Indivior shared data from its phase-three clinical trial evaluating the efficacy, safety and tolerability of its new 'Sublocade' buprenorphine extended-release injectable treatment ...
PDUFA date set for February 7, 2025 If approved by the FDA, label would expand to include alternative injection sites in the thigh, buttock and back of the arm for induction and maintenance as well as ...
Rapid initiation Protocol: Healthcare providers can now initiate treatment with SUBLOCADE after a single dose of transmucosal buprenorphine and a one-hour observation period to confirm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback